Form 4 Filing for 10x Genomics, Inc. - Officer Transaction

This filing details a transaction by John R. Stuelpnagel, a director at 10x Genomics, Inc. On June 4, 2026, Mr. Stuelpnagel acquired 8,829 shares of Class A Common Stock with a transaction price of $0.00 per share. This transaction brings his total post-transaction ownership to 368,436 shares. The filing also includes a Power of Attorney document, appointing Randy Wu and James Bryant as attorneys-in-fact to handle SEC filings on behalf of Mr. Stuelpnagel. This Power of Attorney remains in effect until Mr. Stuelpnagel is no longer required to file. The reported shares acquired are noted as restricted stock units (RSUs), with 1/4 vesting quarterly, contingent upon continued service.